Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004084-37Phase 3Completed
Phase 3, randomised, single-blind trial of permethrin in pediculosis capitis (2 arms), sponsored by SSL International. Primary endpoint: Frequency of adverse events possibly or probably due to treatment. Started Sep 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004084-37.